FROM THE ARCHIVE
Sweat lodge part of cancer treatment
Facebook
Twitter
Email
WEDNESDAY, JULY 18, 2001 When Wauneta Lone Wolf-Cox was first diagnosed with lung cancer in January, the 50-year-old Lakota woman from South Dakota was reluctant to seek treatment using Western methods. But after relying on traditional Native herbs and remedies, she said a Lakota medicine man told her to blend the two worlds. So she has started chemotherapy which is a companion to sweat lodge ceremonies and other traditional treatments. In April, doctors told Lone Wolf-Cox the cancer had spread to her lymph nodes and brain. A benefit is being held in Phoenix, Arizona, for her next Tuesday. Get the Story:
Sweat lodge gives cancer patient hope (The Arizona Republic 7/18)
You may have to register to view Arizona Republic stories. If you do not want to sign up, use the username IndianzCom and password indianz.com (all in lowercase, include the ".") to view the site.
Advertisement
Stay Connected
Contact
Search
Trending in News
1 White House Council on Native American Affairs meets quick demise under Donald Trump
2 'A process of reconnecting': Young Lakota actor finds ways to stay tied to tribal culture
3 Jenni Monet: Bureau of Indian Affairs officer on leave after fatal shooting of Brandon Laducer
4 'A disgraceful insult': Joe Biden campaign calls out Navajo leader for Republican speech
5 Kaiser Health News: Sisters from Navajo Nation died after helping coronavirus patients
2 'A process of reconnecting': Young Lakota actor finds ways to stay tied to tribal culture
3 Jenni Monet: Bureau of Indian Affairs officer on leave after fatal shooting of Brandon Laducer
4 'A disgraceful insult': Joe Biden campaign calls out Navajo leader for Republican speech
5 Kaiser Health News: Sisters from Navajo Nation died after helping coronavirus patients
News Archive
About This Page
You are enjoying stories from the Indianz.Com Archive, a collection dating back to 2000. Some outgoing links may no longer work due to age.
All stories are available for publishing via Creative Commons License: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)